GURUFOCUS.COM » STOCK LIST » Financial Services » Banks » Walker & Dunlop Inc (NYSE:WD) » Definitions » Research & Development

Walker & Dunlop (Walker & Dunlop) Research & Development

: $0 Mil (TTM As of Dec. 2023)
View and export this data going back to 2010. Start your Free Trial

Research & Development is the aggregate amount of research and development expenses during the year. Walker & Dunlop's Research & Development for the three months ended in Dec. 2023 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $0 Mil.


Walker & Dunlop Research & Development Historical Data

The historical data trend for Walker & Dunlop's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Array ( [0] => - [1] => - [2] => - [3] => - [4] => - [5] => - [6] => - [7] => - [8] => - [9] => - )
Walker & Dunlop Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Walker & Dunlop Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Walker & Dunlop Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Walker & Dunlop  (NYSE:WD) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Walker & Dunlop Research & Development Related Terms

Thank you for viewing the detailed overview of Walker & Dunlop's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Walker & Dunlop (Walker & Dunlop) Business Description

Traded in Other Exchanges
Address
7272 Wisconsin Avenue, Suite 1300, Bethesda, MD, USA, 20814
Walker & Dunlop Inc is a United States-based commercial real estate finance company. It is principally engaged in originating, selling and servicing a number of multifamily and other commercial real estate financing products that are sold under the programs of Freddie Mac, Fannie Mae, Ginnie Mae, and the Federal Housing Administration. The company's products consist of first mortgage loans, second trust loans, supplemental financings, construction loans, mezzanine loans, and bridge/interim loans. The company generates a majority of total revenue from gains from mortgage banking activities and servicing fees. It conducts business solely in the United States.
Executives
Smith Howard W Iii director, officer: President 7272 WISCONSIN AVENUE, SUITE 1300, BETHESDA MD 20814
William M Walker director, officer: Chairman & CEO 7272 WISCONSIN AVENUE, SUITE 1300, BETHESDA MD 20814
Stephen P Theobald officer: EVP, CFO & Treasurer 999 WATERSIDE DRIVE, SUITE 200, NORFOLK VA 23510
Richard M Lucas officer: EVP & Gen Counsel & Secretary 7272 WISCONSIN AVENUE, SUITE 1300, BETHESDA MD 20814
Paula A. Pryor officer: EVP & Chief HR Officer C/O WALKER & DUNLOP, INC., 7272 WISCONSIN AVENUE, SUITE 1300, BETHESDA MD 20814
Dana L Schmaltz director 7272 WISCONSIN AVENUE, SUITE 1300, BETHESDA MD 20814
Gregory Florkowski officer: EVP & Chief Financial Officer C/O WALKER & DUNLOP, INC., 7272 WISCONSIN AVENUE, SUITE 1300, BETHESDA MD 20814
Rice E. John Jr director 7272 WISCONSIN AVENUE, SUITE 1300, BETHESDA MD 20814
Donna Wells director BOSTON PRIVATE FINANCIAL HOLDINGS, INC., TEN POST OFFICE SQUARE, BOSTON MA 02109
Michael J. Warren director C/O WALKER & DUNLOP, INC., 7272 WISCONSIN AVENUE, SUITE 1300, BETHESDA MD 20814
Michael D Malone director 2430 LEMON TREE LANE, CHARLOTTE NC 28211
Alan J Bowers director 7272 WISCONSIN AVENUE, SUITE 1300, BETHESDA MD 20814
Richard C Warner officer: EVP & Chief Credit Officer 7501 WISCONSIN AVENUE, SUITE 1200, BETHESDA MD 20814
Ellen Levy director C/O INSTRUCTURE, INC., 6330 SOUTH 3000 EAST, SUITE 700, SALT LAKE CITY UT 84121
Cynthia A Hallenbeck director 7272 WISCONSIN AVENUE, SUITE 1300, BETHESDA MD 20814